Published January 11, 2022 | Version v1
Dataset Open

Virtual screening of the Janssen compound collection against SARS-CoV-2 Mpro

  • 1. Janssen Pharmaceutica NV


This short report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 Mpro and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.


Files (60.5 kB)